JLE

European Journal of Dermatology

MENU

Maculopapular-type drug eruption caused by entecavir Volume 21, numéro 4, July-August 2011

Auteurs
Department of Dermatology, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku Kitakyushu, Japan

ejd.2011.1411 Auteur(s) : Shigenori Yamada, Yu Sawada, Motonobu Nakamura long-ago@med.uoeh-u.ac.jp Department of Dermatology, University of Occupational and Environmental Health, 1-1 Iseigaoka, Yahatanishi-ku Kitakyushu, Japan Entecavir is a potent and highly selective oral nucleoside inhibitor of a hepatitis B virus (HBV) polymerase, with a high antiviral efficacy and a high genetic barrier to viral resistance [1, 2]. Its adverse reactions include headache, upper respiratory tract infection [...]